Atorvastatin Impurity 21(CAS: 125971-94-0)

Atorvastatin Impurity 21 is a chemical compound identified as a specific impurity in the synthesis or degradation of atorvastatin, a cholesterol-lowering medication. It has the chemical formula C23H28O5 and is characterized by its structural similarity to atorvastatin, with variations in functional groups. This impurity is relevant in pharmaceutical quality control and regulatory compliance, as its presence must be monitored to ensure drug safety and efficacy.

Atorvastatin Impurity 21 is primarily used in pharmaceutical research and development for analyzing drug purity, stability studies, and method validation. It serves as a reference standard in analytical testing to detect trace impurities in atorvastatin formulations. Additionally, it is employed in understanding degradation pathways and ensuring adherence to regulatory guidelines such as ICH for drug manufacturing.

Atorvastatin Impurity 21 is generally considered safe when handled properly, but its safety profile depends on exposure levels and application context. Limited toxicity data suggests it is less hazardous than the active drug atorvastatin, yet standard lab safety precautions should be followed, such as wearing gloves and ensuring adequate ventilation. Safety standards in pharmaceutical settings ensure its controlled use in quality assurance processes without compromising patient safety.

Atorvastatin Impurity 21 should be stored in a cool, dry place at 20-25°C, away from light and moisture. It requires airtight containers to maintain stability and prevent contamination. Proper storage conditions are crucial to ensure its shelf life and avoid degradation. Handling should follow guidelines to maintain chemical integrity, such as keeping it in a desiccator or sealed vial.